Neoprobe 3rd Quarter 2011 Earnings and Business Update Conference Call Invitation
October 24 2011 - 11:58AM
Business Wire
Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer
of innovative oncology surgical and diagnostic products, today
announced it would report its financial results for the third
quarter of 2011 on Wednesday, October 26, 2011 after market close.
The announcement will be followed by a conference call with the
investment community the following day, Thursday, October 27 at
8:30 am ET.
Neoprobe’s President and CEO, Dr. Mark Pykett, Senior Vice
President, Pharmaceutical Research and Clinical Development, Dr.
Fred Cope, and Senior Vice President and CFO, Brent Larson, will
provide a development and business update and will discuss the
Company’s financial results for the third quarter of 2011 during
the conference call. The conference call can be accessed as
follows:
Conference Call Information TO PARTICIPATE LIVE:
TO LISTEN TO A REPLAY: Date:
Time:
Toll-free (U.S.) Dial in # :
International Dial in # :
Oct 27, 2011
8:30 AM ET
(877) 407-0778
(201) 689-8565
Available until:
Toll-free (U.S.) Dial in # :
International Dial in # :
Replay passcode:
Account #:
Conference ID #:
Nov 10, 2011
(877) 660-6853
(201) 612-7415
286
381791
About Neoprobe
Neoprobe Corporation (NYSE Amex: NEOP) is a biomedical company
focused on enhancing oncology patient care and improving patient
benefit through radiopharmaceutical product development. Neoprobe
is actively developing two radiopharmaceutical agent platforms –
Lymphoseek® and RIGScanTM CR – to help surgeons better identify and
treat certain types of cancer. Neoprobe’s subsidiary, Cira
Biosciences, Inc., is also exploring development of a
patient-specific cellular therapy technology platform called ACT.
Neoprobe’s strategy is to deliver superior growth and shareholder
return by bringing to market novel radiopharmaceutical agents and
advancing the Company’s pipeline program through continued
investment and selective acquisitions. For more information, please
visit www.neoprobe.com.
Neoprobe Corp. Common Stock (AMEX:NEOP)
Historical Stock Chart
From May 2024 to Jun 2024
Neoprobe Corp. Common Stock (AMEX:NEOP)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Neoprobe Corp. Common Stock (American Stock Exchange): 0 recent articles
More Neoprobe Corporation News Articles